Suppr超能文献

肝素与血管壁的密切关系。

The close relationship of heparin and the vessel wall.

作者信息

Jaques L B, Hiebert L M

机构信息

Dept. of Oral Biology, College of Dentistry, University of Saskatchewan, Saskatoon, Canada.

出版信息

Artery. 1989;16(3):140-50.

PMID:2730347
Abstract

For over 100 years heparin has attracted interest because of its anticoagulant powers. Commercial heparin has now been shown to be a mixture of over 100 different closely related sulfated polysaccharides of which only 10% activate antithrombin-III. Fifty years ago the original research teams in Toronto and Stockholm in demonstrating the clinical uses of heparin observed that antithrombotic activity did not correspond to levels of anticoagulation. It has been shown that: (a) Heparin accumulates rapidly and specifically in the endothelium against a concentration gradient of hundreds- to thousands-fold. (b) Experimental thrombosis, however produced, is accompanied by a marked decrease in the electronegative charge of the vessel wall and the charge is restored in all cases by heparin. (c) The normal electronegative charge is due to glycosaminoglycans. Heparin possesses the strongest electronegative charge of these substances and is present in the vessel wall as a component of a larger heparitin (sulfate) proteoglycan molecule. (d) Maintenance of the normal electronegative charge depends on adequate supply of oxygen (adequate blood flow). (e) Commercial heparin releases enzymes from the endothelium, lipoprotein lipase and histaminase (D.A.O.). Lipoprotein lipase changes the composition of plasma lipids and lipoproteins and histaminase provides a check for fat absorption. The release of these enzymes decrease and prevent atherosclerotic changes. (f) After administration of commercial heparin, heparin isolated from the plasma has higher antithrombin activity than that injected. The heparin taken up by the endothelium is returned with greater activity. The anticoagulant effect of administered heparin does not produce hemorrhage since this requires simultaneous occurrence of defects in the vascular factor of hemostasis (the result of stress or pituitary-adrenal imbalance) or platelet defect. Thus, clinical effectiveness of heparin is an expression of its close relationship to the vessel wall.

摘要

100多年来,肝素因其抗凝能力而备受关注。现已证明,商业用肝素是100多种不同的密切相关的硫酸化多糖的混合物,其中只有10%能激活抗凝血酶III。50年前,多伦多和斯德哥尔摩的最初研究团队在证明肝素的临床用途时观察到,抗血栓活性与抗凝水平并不对应。现已表明:(a)肝素以数百至数千倍的浓度梯度快速且特异性地在内皮中蓄积。(b)然而产生的实验性血栓形成伴随着血管壁负电荷的显著降低,并且在所有情况下肝素都能使电荷恢复。(c)正常的负电荷归因于糖胺聚糖。肝素在这些物质中具有最强的负电荷,并作为较大的类肝素(硫酸盐)蛋白聚糖分子的一种成分存在于血管壁中。(d)正常负电荷的维持取决于充足的氧气供应(充足的血流)。(e)商业用肝素可从内皮中释放酶,即脂蛋白脂肪酶和组胺酶(二胺氧化酶)。脂蛋白脂肪酶改变血浆脂质和脂蛋白的组成,组胺酶可抑制脂肪吸收。这些酶的释放可减少并预防动脉粥样硬化改变。(f)给予商业用肝素后,从血浆中分离出的肝素比注射的肝素具有更高的抗凝血酶活性。被内皮摄取的肝素会以更高的活性返回。所给予肝素的抗凝作用不会导致出血,因为这需要同时出现止血血管因子缺陷(应激或垂体 - 肾上腺失衡的结果)或血小板缺陷。因此,肝素的临床有效性体现了其与血管壁的密切关系。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验